Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J van Moorsel

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Human Molecular Genetics|June 1, 1993
TaqI and RsaI polymorphisms in the H19 gene (D11S813E)E Redeker, C J Van Moorsel, A Feinberg, et al.
Advances in Experimental Medicine and Biology|May 23, 1998
Induction of in vivo resistance against gemcitabine (dFdC, 2',2'-difluoro-deoxycytidine)V W Ruiz van Haperen, G Veerman, C J van Moorsel, et al.
International Journal of Oncology|June 16, 2001
Interference of gemcitabine triphosphate with the measurements of deoxynucleotides using an optimized DNA polymerase elongation assayK Smid, C J Van Moorsel, P Noordhuis, et al.
European Journal of Cancer (Oxford, England : 1990)|September 23, 2000
Cross-resistance in the 2',2'-difluorodeoxycytidine (gemcitabine)-resistant human ovarian cancer cell line AG6000 to standard and investigational drugsA M Bergman, G Giaccone, C J van Moorsel, et al.
Seminars in Oncology|April 1, 1997
Combination chemotherapy studies with gemcitabineC J van Moorsel, G Veerman, A M Bergman, et al.
Pharmacology & Therapeutics|September 29, 2000
Basis for effective combination cancer chemotherapy with antimetabolitesG J Peters, C L van der Wilt, C J van Moorsel, et al.
Cancer Letters|May 8, 1995
Vitamin A and beta-carotene influence the level of benzo[a]pyrene-induced DNA adducts and DNA-repair activities in hamster tracheal epithelium in organ cultureA P Wolterbeek, R Roggeband, C J van Moorsel, et al.
Anti-Cancer Drugs|September 7, 1999
Selective cell kill of the combination of gemcitabine and cisplatin in multilayered postconfluent tumor cell culturesJ M Padrón, C J van Moorsel, A M Bergman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2000
Gemcitabine-cisplatin: a schedule finding studyJ R Kroep, G J Peters, C J van Moorsel, et al.
Advances in Experimental Medicine and Biology|May 23, 1998
Differential effects of gemcitabine on nucleotide pools of 19 solid tumor cell linesC J van Moorsel, G Veerman, V W Ruiz van Haperen, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Human Molecular Genetics|June 1, 1993
TaqI and RsaI polymorphisms in the H19 gene (D11S813E)E Redeker, C J Van Moorsel, A Feinberg, et al.
Advances in Experimental Medicine and Biology|May 23, 1998
Induction of in vivo resistance against gemcitabine (dFdC, 2',2'-difluoro-deoxycytidine)V W Ruiz van Haperen, G Veerman, C J van Moorsel, et al.
International Journal of Oncology|June 16, 2001
Interference of gemcitabine triphosphate with the measurements of deoxynucleotides using an optimized DNA polymerase elongation assayK Smid, C J Van Moorsel, P Noordhuis, et al.
European Journal of Cancer (Oxford, England : 1990)|September 23, 2000
Cross-resistance in the 2',2'-difluorodeoxycytidine (gemcitabine)-resistant human ovarian cancer cell line AG6000 to standard and investigational drugsA M Bergman, G Giaccone, C J van Moorsel, et al.
Seminars in Oncology|April 1, 1997
Combination chemotherapy studies with gemcitabineC J van Moorsel, G Veerman, A M Bergman, et al.
Pharmacology & Therapeutics|September 29, 2000
Basis for effective combination cancer chemotherapy with antimetabolitesG J Peters, C L van der Wilt, C J van Moorsel, et al.
Cancer Letters|May 8, 1995
Vitamin A and beta-carotene influence the level of benzo[a]pyrene-induced DNA adducts and DNA-repair activities in hamster tracheal epithelium in organ cultureA P Wolterbeek, R Roggeband, C J van Moorsel, et al.
Anti-Cancer Drugs|September 7, 1999
Selective cell kill of the combination of gemcitabine and cisplatin in multilayered postconfluent tumor cell culturesJ M Padrón, C J van Moorsel, A M Bergman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2000
Gemcitabine-cisplatin: a schedule finding studyJ R Kroep, G J Peters, C J van Moorsel, et al.
Advances in Experimental Medicine and Biology|May 23, 1998
Differential effects of gemcitabine on nucleotide pools of 19 solid tumor cell linesC J van Moorsel, G Veerman, V W Ruiz van Haperen, et al.
Pageof 2